About Dr. Mohit Saxena
Dr. Mohit Saxena is a distinguished Consultant Medical Oncologist and Hematologist based in Gurgaon, widely recognised as a leading Medical Oncologist specialist in Gurgaon, India for chemotherapy (intravenous, intrathecal, intraperitoneal HIPEC, oral metronomic), immunotherapy, targeted therapy, precision medicine, and hormone therapy across solid and hematological malignancies.
- 10-19+ years of clinical experience including 9+ years as a cancer specialist
- MBBS from Sawai Man Singh (S.M.S.) Medical College, Jaipur
- MD in General Medicine from Sawai Man Singh Medical College, Jaipur
- DM in Medical Oncology from Gujarat Cancer Research Institute (G.C.R.I.), Ahmedabad (2016)
- Currently Consultant - Medical Oncology at Manipal Hospitals Gurugram - Delhi NCR
- Founder of The Onco Clinic, Sector 38, Gurgaon
- Senior Resident at Gujarat Cancer & Research Institute, Ahmedabad (Mar 2016 – Sept 2016)
- Principal Investigator in LAURA and ADRIATIC studies; Co-investigator in NEPTUNE, KESTREL, HIMALAYA, MonarchE, KEYNOTE-593 studies
- Numerous publications in national and international journals
Qualifications & Credentials
Medical Degrees
- MBBS — Sawai Man Singh (S.M.S.) Medical College, Jaipur, India
- MD in General Medicine — Sawai Man Singh Medical College, Jaipur, India
- DM in Medical Oncology — Gujarat Cancer Research Institute (G.C.R.I.), Ahmedabad, India, 2016
Fellowships & Special Training
- Senior Resident — Department of Medical Oncology, Gujarat Cancer & Research Institute, Ahmedabad (March 2016 – September 2016)
- Specialised training in Solid Tumour Treatment
- Specialised training in Hematological Malignancies
- Advanced training in Chemotherapy (Intravenous, Intrathecal, Intraperitoneal HIPEC, Oral Metronomic)
- Specialised training in Immunotherapy
- Advanced training in Targeted Therapy & Precision Medicine
- Specialised training in Hormone Therapy
- Participation in 20th National CMI in Haematology (Jan–Feb 2015)
- Zonal round of Torrent Young Scholar Award (TYSA) Programme (Dec 2014)
- Good Clinical Practice Workshop (Dec 2012)
Certifications & Accreditations
- Haryana Medical Council — Registered
- National Medical Commission / Medical Council of India Registration
- Board-Certified Specialist — Internal Medicine (MD)
- Board-Certified Super-Specialist — Medical Oncology (DM)
- 9th Merit — 12th Board of Secondary Education, Rajasthan, 1998
Areas of Expertise
Major Conditions Treated
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancers (Oesophagus, Stomach, Colon, Rectal)
- Hepatobiliary Cancers (Hepatocellular, Gall Bladder, Bile Duct)
- Genitourinary Cancers (Prostate, Bladder)
- Renal Cell Carcinoma
- Head and Neck Cancer
- Gynaecological Cancers (Ovarian, Cervical, Uterine)
- Sarcomas
- Leukaemia (AML, ALL, CML, CLL, Acute Promyelocytic Leukaemia)
- Lymphoma (Hodgkin, Non-Hodgkin)
- Multiple Myeloma
- Blood Disorders (Anaemia, Thrombocytopenia)
- Recurrent Cancers
Sub-specialties
- Solid Tumour Oncology: GI, hepatobiliary, genitourinary, gynaecological, breast, lung, head & neck, sarcoma — establishes him as a trusted medical oncologist specialist in Gurgaon, India.
- Haemato-Oncology: Comprehensive management of leukaemia, lymphoma, multiple myeloma, and benign blood disorders.
- Chemotherapy (All Routes): Specialist in intravenous, intrathecal, intraperitoneal (HIPEC), and oral metronomic chemotherapy.
- Immunotherapy & Targeted Therapy: Specialised expertise in latest immune checkpoint inhibitors and targeted molecular therapy — for international patients seeking best cancer treatment in India.
- Precision Medicine: Specialist in genomic-driven personalised cancer therapy.
- Clinical Trial Research: Principal Investigator in LAURA and ADRIATIC studies; Co-investigator in 5+ international trials.
Advanced Procedures & Treatments
- Chemotherapy — Intravenous (IV)
- Chemotherapy — Intrathecal
- Chemotherapy — Intraperitoneal / HIPEC (Hyperthermic Intraperitoneal Chemotherapy)
- Chemotherapy — Oral Metronomic Therapy
- Targeted Therapy & Precision Medicine
- Immunotherapy
- Hormone Therapy (including for Breast Cancer)
- Bone Marrow Aspiration & Biopsy
- Comprehensive Cancer Treatment Coordination
- Acute Promyelocytic Leukaemia Treatment
- Renal Cell Carcinoma — Sorafenib First-Line Therapy
- High-Dose Cytarabine Therapy for AML
- Cancer Screening & Diagnostic Workup
List of Disease and Treatment for which Dr. Mohit Saxena can be consulted
Professional Experience
Current Affiliation
- Manipal Hospitals Gurugram - Delhi NCR, Palam Vihar — Consultant, Medical Oncology, Present
- The Onco Clinic, Sector 38, Gurgaon — Founder & Chief Consultant, Present
- D Mettle Clinique, 301-A & 303-A, 3rd Floor, Unitech Arcadia, South City II, Sector 49, Gurgaon (Super Speciality Polyclinic OPD Care) — Consultant, Present
- Asha Multi Speciality Clinic, Sector 40, Gurgaon — Consultant, Present
- Narayana Health, Gurugram — Consultant Haemato-Oncology / Medical Oncology (Associated)
Past Affiliations
- Artemis Hospital, Gurgaon — Consultant, Medical Oncology (November 2016 – June 2019, 2.5 years)
- VPS Rockland Hospital, Qutub & Manesar — Associate Consultant, Medical Oncology (April 2017 – July 2018)
- C.K. Birla Hospital, Gurgaon — Consultant, Medical Oncology (June 2019 – August 2020)
- Paras Hospital, Gurgaon — Consultant, Medical Oncology (July 2019 – December 2019)
- Fortis Hospital, Vasant Kunj, New Delhi — Empanelled Consultant, Medical Oncology (January 2020 – August 2020)
- Gujarat Cancer & Research Institute, Ahmedabad — Senior Resident, Medical Oncology (March 2016 – September 2016)
- G.C.S. Medical College & Hospital, Ahmedabad — Associate Professor (Previous)
- Sawai Man Singh Medical College, Jaipur — MD General Medicine Resident
Academic & Research Roles
- Consultant — Medical Oncology, Manipal Hospitals Gurugram
- Founder & Chief Consultant — The Onco Clinic, Sector 38, Gurgaon
- Author — Multiple peer-reviewed publications in national and international journals
- Principal Investigator — LAURA Study, ADRIATIC Study
- Co-investigator — NEPTUNE Study, KESTREL Study, HIMALAYA Study, MonarchE Study, KEYNOTE-593 Study
- Active speaker — National medical oncology conferences and CMEs
Key Achievements
- 10-19+ years of clinical experience (9+ years as cancer specialist)
- DM in Medical Oncology from Gujarat Cancer Research Institute (one of India's apex regional cancer centres)
- Consultant - Medical Oncology at Manipal Hospitals Gurugram
- Founder of The Onco Clinic, Sector 38, Gurgaon
- 2.5 years senior consultant role at Artemis Hospital, Gurgaon
- Principal Investigator in LAURA and ADRIATIC clinical trials
- Co-investigator in NEPTUNE, KESTREL, HIMALAYA, MonarchE, and KEYNOTE-593 international studies
- Numerous publications in national and international journals on acute promyelocytic leukaemia, metastatic renal cell carcinoma, AML leukoencephalopathy, and primary anaemia
- 9th Merit in 12th Board of Secondary Education, Rajasthan, 1998
Awards & Recognitions
National & International Awards
- 9th Merit — 12th Board of Secondary Education, Rajasthan, 1998
- Participation — 20th National CMI in Haematology (Jan–Feb 2015)
- Zonal round — Torrent Young Scholar Award (TYSA) Programme (Dec 2014)
- Principal Investigator — LAURA Study and ADRIATIC Study
Professional Memberships
- Indian Society of Medical and Paediatric Oncology (ISMPO) — Member
- Indian Medical Association (IMA) — Member
- Haryana Medical Council — Registered
- European Society of Medical Oncology (ESMO) — Member
- American Society of Clinical Oncology (ASCO) — Member
Research & Publications
Published Papers (Selected)
- Saxena M, Madabhavi I, Patel A et al. "Treating low- and intermediate-risk acute promyelocytic leukaemia with and without chemotherapy: A comparison in a tertiary care centre." Journal of Cancer Research and Therapeutics, 2023 April; DOI: 10.4103/jcrt.jcrt_436_21.
- Saxena M, Madabhavi I, Patel A et al. "Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre." International Journal of Hematology Oncology and Stem Cell Research, 2018 July 1; 12(3): 197–203.
- Saxena M, Panchal HP, Parikh SK et al. "High-dose Cytarabine-arabinoside (Ara-C) as a culprit of leukoencephalopathy in a patient of acute myeloid leukemia." Vidarbha Journal of Internal Medicine, 2015 July; 19: 63–66.
- Saxena M, Rao RS, Sharma BB et al. "Primary Anaemia (Haematological Causes): A Prevalence Study in A Tertiary Care Centre." Current Medical Trends, 2008; 12: 2318–24.
Ongoing Research & Clinical Interests
- Solid tumour oncology (GI, hepatobiliary, genitourinary, gynaecological, breast, lung, head & neck, sarcoma)
- Haemato-oncology (leukaemia, lymphoma, multiple myeloma, anaemia, thrombocytopenia)
- Acute Promyelocytic Leukaemia treatment
- Metastatic Renal Cell Carcinoma — Sorafenib first-line
- Immunotherapy and targeted therapy
- Precision medicine
- HIPEC and oral metronomic chemotherapy
- Clinical trial research (LAURA, ADRIATIC, NEPTUNE, KESTREL, HIMALAYA, MonarchE, KEYNOTE-593)
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹1,500 – ₹2,500 | $18 – $30 |
| Chemotherapy (per cycle) | ₹25,000 – ₹2,50,000 | $300 – $3,000 |
| Targeted Therapy / Immunotherapy (per cycle) | ₹1,50,000 – ₹6,00,000 | $1,800 – $7,200 |
| HIPEC (Hyperthermic Intraperitoneal Chemotherapy) | ₹4,00,000 – ₹10,00,000 | $4,800 – $12,000 |
| Oral Metronomic Chemotherapy (per month) | ₹15,000 – ₹50,000 | $180 – $600 |
| Bone Marrow Aspiration & Biopsy | ₹8,000 – ₹25,000 | $100 – $300 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Mohit Saxena use in Medical Oncologist treatment?
Dr. Mohit Saxena uses advanced chemotherapy across all routes — intravenous, intrathecal, intraperitoneal HIPEC, and oral metronomic — modern targeted therapy and precision medicine, immunotherapy with latest immune checkpoint inhibitors, hormone therapy for breast cancer, comprehensive bone marrow aspiration and biopsy, and integrated cancer treatment coordination — a cutting-edge toolkit refined through GCRI Ahmedabad super-speciality training and active clinical trial leadership in international studies (LAURA, ADRIATIC, NEPTUNE, KESTREL, HIMALAYA, MonarchE, KEYNOTE-593) that establishes him as a leading medical oncologist specialist in Gurgaon, India.
2. What conditions does Dr. Mohit Saxena specialize in treating?
Dr. Mohit Saxena specialises in breast cancer, lung cancer, gastrointestinal cancers (oesophagus, stomach, colon, rectal), hepatobiliary cancers (hepatocellular, gall bladder, bile duct), genitourinary cancers (prostate, bladder), renal cell carcinoma, head and neck cancer, gynaecological cancers (ovarian, cervical, uterine), sarcomas, leukaemia (AML, ALL, CML, CLL, acute promyelocytic leukaemia), lymphoma (Hodgkin and Non-Hodgkin), multiple myeloma, blood disorders (anaemia, thrombocytopenia), and recurrent cancers — comprehensive care for international patients seeking best cancer treatment in India.
3. How do I book an appointment with Dr. Mohit Saxena?
Appointments with Dr. Mohit Saxena can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Mohit Saxena?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Mohit Saxena, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Mohit Saxena offer second opinions for Medical Oncologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert medical oncologist specialist in Gurgaon, India, especially for complex acute promyelocytic leukaemia, metastatic renal cell carcinoma, breast cancer, lung cancer, GI cancer, and clinical trial candidate cases.














